Singing River Skilled Nursing Facility in Pascagoula, MS

Singing River Skilled Nursing Facility is a medicare certified nursing home in Pascagoula, Mississippi. It is located in Jackson county at 2809 Denny Avenue, Pascagoula, Mississippi 39581. You can reach out to the office of Singing River Skilled Nursing Facility via phone at (228) 809-1030. This skilled nursing facility has 36 federally certified beds with average occupancy rate of 80%. Its legal business name is Singing River Health System and has the following ownership type - Non Profit - Corporation.

Singing River Skilled Nursing Facility (Medicare CCN 255346) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2017 (7 years certified) and the last quality survey was conducted in February, 2020.

Name	Singing River Skilled Nursing Facility
Location	2809 Denny Avenue, Pascagoula, Mississippi
Certified By	Medicare
No. of Certified Beds	36
Occupancy Rate	80%
Medicare ID (CCN)	255346
Legal Business Name	Singing River Health System
Ownership Type	Non Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Singing River Skilled Nursing Facility from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1548700909
Organization Name	SINGING RIVER HEALTH SYSTEM
Doing Business As	SINGING RIVER SKILLED NURSING FACILITY
Address	2809 Denny Ave, Pascagoula, MS 39581
Phone Number	228-809-5000

News Archive

AVAC: MDP 301 effectiveness trial finds no evidence that PRO 2000 microbicide reduces HIV infection

The Microbicides Development Programme announced earlier today that its MDP 301 effectiveness trial, which was conducted among almost 9,400 women in four African countries, found no evidence that the PRO 2000 microbicide reduces the risk of HIV infection.

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

A molecular switch for repairing damage in central nervous system disorders discovered

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis, Mayo Clinic researchers discovered.

Arana files U.S. IND for lead anti-Inflammatory

Biotechnology company Arana Therapeutics Limited today announced it has submitted an Investigational New Drug application (IND) to the FDA (U.S. Food and Drug Administration) for the anti-inflammatory product ART621 in a rheumatoid arthritis (RA) indication.

Read more Medical News

› Verified 5 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Singing River Skilled Nursing Facility are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Singing River Skilled Nursing Facility give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

AVAC: MDP 301 effectiveness trial finds no evidence that PRO 2000 microbicide reduces HIV infection

The Microbicides Development Programme announced earlier today that its MDP 301 effectiveness trial, which was conducted among almost 9,400 women in four African countries, found no evidence that the PRO 2000 microbicide reduces the risk of HIV infection.

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

A molecular switch for repairing damage in central nervous system disorders discovered

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis, Mayo Clinic researchers discovered.

Arana files U.S. IND for lead anti-Inflammatory

Biotechnology company Arana Therapeutics Limited today announced it has submitted an Investigational New Drug application (IND) to the FDA (U.S. Food and Drug Administration) for the anti-inflammatory product ART621 in a rheumatoid arthritis (RA) indication.

Read more Medical News

› Verified 5 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Singing River Skilled Nursing Facility is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.